{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:44:35Z","timestamp":1790286275711,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.semradonc.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T23:41:56Z","timestamp":1710805316000},"page":"218-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?"],"prefix":"10.1016","volume":"34","author":[{"given":"Keith A.","family":"Cengel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Diffenderfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"De Ruysscher","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"1093","key":"10.1016\/j.semradonc.2024.02.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180008","article-title":"Expanding the therapeutic index of radiation therapy by normal tissue protection","volume":"92","author":"Montay-Gruel","year":"2019","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0003","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.hoc.2019.08.004","article-title":"Radiation modifiers","volume":"33","author":"Citrin","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"issue":"13","key":"10.1016\/j.semradonc.2024.02.001_bib0004","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1245\/s10434-018-6789-7","article-title":"Fine tuning the radiation treatment for extremity soft tissue sarcomas","volume":"25","author":"DeLaney","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0005","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2012.01.062","article-title":"Radiotherapy for management of extremity soft tissue sarcomas: Why, when, and where?","volume":"84","author":"Haas","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9325","key":"10.1016\/j.semradonc.2024.02.001_bib0006","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial","volume":"359","author":"O'Sullivan","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.semradonc.2024.02.001_bib0007","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bjps.2019.05.041","article-title":"Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analyses","volume":"72","author":"Slump","year":"2019","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0008","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"Davis","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/289673","article-title":"Incidence and severity of lymphoedema following limb salvage of extremity soft tissue sarcoma","volume":"2011","author":"Friedmann","year":"2011","journal-title":"Sarcoma"},{"issue":"4","key":"10.1016\/j.semradonc.2024.02.001_bib0010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0360-3016(90)90010-H","article-title":"Preoperative irradiation for soft tissue sarcomas of the trunk and extremities in adults","volume":"19","author":"Brant","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semradonc.2024.02.001_bib0011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.ijrobp.2008.12.006","article-title":"Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: Relationship to irradiated bone length, volume, tumor location and dose","volume":"75","author":"Dickie","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.semradonc.2024.02.001_bib0012","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjsurg.2005.09.007","article-title":"Late treatment-related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy","volume":"191","author":"Livi","year":"2006","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0013","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0360-3016(91)90324-W","article-title":"Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma","volume":"21","author":"Stinson","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.semradonc.2024.02.001_bib0014","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ijrobp.2017.08.018","article-title":"Hospital quality factors influencing the mobility of patients for radical prostate cancer radiation therapy: A national population-based study","volume":"99","author":"Aggarwal","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2019.06.015","article-title":"National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project","volume":"138","author":"Defourny","year":"2019","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.semradonc.2024.02.001_bib0016","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/PPO.0000000000000204","article-title":"Stereotactic body radiation therapy for early-stage lung cancer","volume":"22","author":"Maquilan","year":"2016","journal-title":"Cancer J"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0017","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/JU.0000000000000071","article-title":"Hypofractionated radiation therapy for localized prostate cancer: Executive summary of an ASTRO, ASCO and AUA evidence-based guideline","volume":"201","author":"Morgan","year":"2019","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.semradonc.2024.02.001_bib0018","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14737140.2018.1489245","article-title":"Hypofractionated radiation treatment in the management of breast cancer","volume":"18","author":"Gupta","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9","key":"10.1016\/j.semradonc.2024.02.001_bib0019","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1245\/s10434-020-09526-y","article-title":"Ultra-short fraction schedules as part of de-intensification strategies for early-stage breast cancer","volume":"28","author":"Shah","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2024.02.001_bib0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(20)30581-7","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): Patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial","volume":"22","author":"Fransson","year":"2021","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.semradonc.2024.02.001_bib0021","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.clon.2020.05.001","article-title":"Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic","volume":"32","author":"Faivre-Finn","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"12","key":"10.1016\/j.semradonc.2024.02.001_bib0022","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ejso.2014.05.016","article-title":"Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas","volume":"40","author":"Kosela-Paterczyk","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0023","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.adro.2020.06.024","article-title":"Early outcomes of preoperative 5-fraction radiation therapy for soft tissue sarcoma followed by immediate surgical resection","volume":"5","author":"Parsai","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"12","key":"10.1016\/j.semradonc.2024.02.001_bib0024","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/COC.0000000000000443","article-title":"Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas","volume":"41","author":"Pennington","year":"2018","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1016\/j.semradonc.2024.02.001_bib0025","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1078-0432.CCR-19-3524","article-title":"A phase II trial of 5-day neoadjuvant radiotherapy for patients with high-risk primary soft tissue sarcoma","volume":"26","author":"Kalbasi","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"4 Suppl 4","key":"10.1016\/j.semradonc.2024.02.001_bib0026","first-page":"3","article-title":"The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation","volume":"20","author":"Appelbaum","year":"1993","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0027","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/09553006914551761","article-title":"Ultra-high dose-rate effects in radiosensitive bacteria","volume":"14","author":"Phillips","year":"1969","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0028","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/09553006914550871","article-title":"The repair time of chromosome breaks induced by pulsed x-rays on ultra-high dose-rate","volume":"15","author":"Prempree","year":"1969","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0029","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01189087","article-title":"The effect of ultra-high dose-rate beta-ray irradiation in aerobic and hypoxic conditions on the survival of diploid yeast","volume":"6","author":"Kiefer","year":"1970","journal-title":"Biophysik"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2307\/3575178","article-title":"Dose-rate effects on the cell cycle and survival of S3 HeLa and V79 cells","volume":"79","author":"Mitchell","year":"1979","journal-title":"Radiat Res"},{"issue":"5","key":"10.1016\/j.semradonc.2024.02.001_bib0031","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1667\/RR1539.1","article-title":"No evidence for a different RBE between pulsed and continuous 20 MeV protons","volume":"172","author":"Schmid","year":"2009","journal-title":"Radiat Res"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0032","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.radonc.2010.03.010","article-title":"Relative biological effectiveness of pulsed and continuous 20 MeV protons for micronucleus induction in 3D human reconstructed skin tissue","volume":"95","author":"Schmid","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0033","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1748-717X-6-139","article-title":"Survival of tumor cells after proton irradiation with ultra-high dose rates","volume":"6","author":"Auer","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0034","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/mp.16271","article-title":"Ultra-high dose rate FLASH radiation therapy for cancer","volume":"50 Suppl 1","author":"Kim","year":"2023","journal-title":"Med Phys"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0035","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/mp.14885","article-title":"Commissioning of an ultra-high dose rate pulsed electron beam medical LINAC for FLASH RT preclinical animal experiments and future clinical human protocols","volume":"48","author":"Moeckli","year":"2021","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0036","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.radonc.2017.05.003","article-title":"Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy\/s","volume":"124","author":"Montay-Gruel","year":"2017","journal-title":"Radiotherap Oncol"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0037","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1078-0432.CCR-17-3375","article-title":"The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients","volume":"25","author":"Vozenin","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0038","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2016.09.018","article-title":"Experimental platform for ultra-high dose rate FLASH irradiation of small animals using a clinical linear accelerator","volume":"97","author":"Sch\u00fcler","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0039","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.radonc.2019.01.031","article-title":"Modifying a clinical linear accelerator for delivery of ultra-high dose rate irradiation","volume":"139","author":"Lempart","year":"2019","journal-title":"Radiotherap Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0040","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ijrobp.2021.01.011","article-title":"Electron FLASH delivery at treatment room isocenter for efficient reversible conversion of a clinical LINAC","volume":"110","author":"Rahman","year":"2021","journal-title":"Int J Rad Oncol* Biol* Phys"},{"issue":"2","key":"10.1016\/j.semradonc.2024.02.001_bib0041","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijrobp.2019.10.049","article-title":"Design, implementation, and in vivo validation of a novel proton flash radiotherapy system","volume":"106","author":"Diffenderfer","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0042","doi-asserted-by":"crossref","unstructured":"Girdhani S, Abel E, Katsis A, et al. FLASH: A novel paradigm changing tumor irradiation platform that enhances therapeutic ratio by reducing normal tissue toxicity and activating immune pathways. Cancer Res, 79(13), pp. LB-280.","DOI":"10.1158\/1538-7445.AM2019-LB-280"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0043","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.radonc.2019.06.024","article-title":"Feasibility of proton FLASH effect tested by zebrafish embryo irradiation","volume":"139","author":"Beyreuther","year":"2019","journal-title":"Radiotherap Oncol"},{"issue":"16","key":"10.1016\/j.semradonc.2024.02.001_bib0044","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.3390\/cancers13164244","article-title":"Comparison of FLASH proton entrance and the spread-out Bragg peak dose regions in the sparing of mouse intestinal crypts and in a pancreatic tumor model","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.semradonc.2024.02.001_bib0045","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1002\/mp.15021","article-title":"Spread-out Bragg peak proton FLASH irradiation using a clinical synchrocyclotron: Proof of concept and ion chamber characterization","volume":"48","author":"Darafsheh","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0046","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1002\/mp.14253","article-title":"Feasibility of proton FLASH irradiation using a synchrocyclotron for preclinical studies","volume":"47","author":"Darafsheh","year":"2020","journal-title":"Med Phys"},{"issue":"5","key":"10.1016\/j.semradonc.2024.02.001_bib0047","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3390\/cancers13051012","article-title":"FLASH proton pencil beam scanning irradiation minimizes radiation-induced leg contracture and skin toxicity in mice","volume":"13","author":"Cunningham","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0048","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamaoncol.2022.5843","article-title":"Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: The FAST-01 nonrandomized trial","volume":"9","author":"Mascia","year":"2023","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0049","doi-asserted-by":"crossref","first-page":"06NT1","DOI":"10.1088\/1361-6560\/abe55a","article-title":"Considerations for shoot-through FLASH proton therapy","volume":"66","author":"Verhaegen","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0050","article-title":"FLASH radiotherapy using single-energy proton PBS transmission beams for hypofractionation liver cancer: Dose and dose rate quantification","volume":"11","author":"Wei","year":"2021","journal-title":"Front Oncol"},{"issue":"22","key":"10.1016\/j.semradonc.2024.02.001_bib0051","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.3390\/cancers13225790","article-title":"A novel proton pencil beam scanning FLASH RT delivery method enables optimal OAR sparing and ultra-high dose rate delivery: A comprehensive dosimetry study for lung tumors","volume":"13","author":"Wei","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.semradonc.2024.02.001_bib0052","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.3390\/cancers15153828","article-title":"Proton Bragg peak FLASH enables organ sparing and ultra-high dose-rate delivery: Proof of principle in recurrent head and neck cancer","volume":"15","author":"Pennock","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0053","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.radonc.2022.08.003","article-title":"Treatment planning considerations for the development of FLASH proton therapy","volume":"175","author":"Rothwell","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0054","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.radonc.2022.08.005","article-title":"Advanced pencil beam scanning Bragg peak FLASH-RT delivery technique can enhance lung cancer planning treatment outcomes compared to conventional multiple-energy proton PBS techniques","volume":"175","author":"Wei","year":"2022","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.semradonc.2024.02.001_bib0055","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1002\/mp.15894","article-title":"Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy","volume":"49","author":"Wei","year":"2022","journal-title":"Med Phys"},{"issue":"23","key":"10.1016\/j.semradonc.2024.02.001_bib0056","doi-asserted-by":"crossref","first-page":"23TR03","DOI":"10.1088\/1361-6560\/abaa28","article-title":"Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: A topical review","volume":"65","author":"Esplen","year":"2020","journal-title":"Phys Med Biol"},{"issue":"15","key":"10.1016\/j.semradonc.2024.02.001_bib0057","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.3390\/cancers15153883","article-title":"FLASH radiotherapy and the use of radiation dosimeters","volume":"15","author":"Siddique","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1148","key":"10.1016\/j.semradonc.2024.02.001_bib0058","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220560","article-title":"Recent developments in absolute dosimetry for FLASH radiotherapy","volume":"96","author":"Subiel","year":"2023","journal-title":"Br J Radiol"},{"issue":"7","key":"10.1016\/j.semradonc.2024.02.001_bib0059","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1002\/mp.15649","article-title":"Ultra-high dose rate dosimetry: Challenges and opportunities for FLASH radiation therapy","volume":"49","author":"Romano","year":"2022","journal-title":"Med Phys"},{"issue":"5","key":"10.1016\/j.semradonc.2024.02.001_bib0060","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ijrobp.2023.04.018","article-title":"Framework for quality assurance of ultrahigh dose rate clinical trials investigating FLASH effects and current technology gaps","volume":"116","author":"Zou","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0061","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2010.02.016","article-title":"Particle therapy at the Heidelberg Ion Therapy Center (HIT)\u2013Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany","volume":"95","author":"Combs","year":"2010","journal-title":"Radiotherap Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0062","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/S0167-8140(04)80046-X","article-title":"The Heidelberg ion therapy center","volume":"73","author":"Haberer","year":"2004","journal-title":"Radiotherap Oncol"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0063","doi-asserted-by":"crossref","first-page":"T03004","DOI":"10.1088\/1748-0221\/16\/03\/T03004","article-title":"A facility for the research, development, and translation of advanced technologies for ion-beam therapies","volume":"16","author":"Lis","year":"2021","journal-title":"J Instrumentation"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0064","doi-asserted-by":"crossref","first-page":"12044","DOI":"10.1038\/s41598-018-30543-1","article-title":"Comparative toxicity of synchrotron and conventional radiation therapy based on total and partial body irradiation in a murine model","volume":"8","author":"Smyth","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.radonc.2018.08.016","article-title":"X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice","volume":"129","author":"Montay-Gruel","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0066","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/mp.16609","article-title":"Dosimetric characterization of a rotating anode x-ray tube for FLASH radiotherapy research","volume":"51","author":"Miles","year":"2024","journal-title":"Med Phys"},{"issue":"9","key":"10.1016\/j.semradonc.2024.02.001_bib0067","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abf2fa","article-title":"Ultrahigh dose-rate (FLASH) x-ray irradiator for pre-clinical laboratory research","volume":"66","author":"Rezaee","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0068","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2021.11.004","article-title":"First demonstration of the FLASH effect with ultrahigh dose rate high-energy X-rays","volume":"166","author":"Gao","year":"2022","journal-title":"Radiotherap Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0069","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2019.05.005","article-title":"PHASER: A platform for clinical translation of FLASH cancer radiotherapy","volume":"139","author":"Maxim","year":"2019","journal-title":"Radiotherap Oncol"},{"issue":"2","key":"10.1016\/j.semradonc.2024.02.001_bib0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s13246-023-01266-z","article-title":"The current status of FLASH particle therapy: A systematic review","volume":"46","author":"Atkinson","year":"2023","journal-title":"Phys Eng Sci Med"},{"issue":"10","key":"10.1016\/j.semradonc.2024.02.001_bib0071","doi-asserted-by":"crossref","first-page":"e13790","DOI":"10.1002\/acm2.13790","article-title":"A potential revolution in cancer treatment: A topical review of FLASH radiotherapy","volume":"23","author":"Gao","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0072","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3389\/fonc.2019.01563","article-title":"Ultra-high dose rate (FLASH) radiotherapy: silver bullet or fool's gold?","volume":"9","author":"Wilson","year":"2019","journal-title":"Front Oncol"},{"issue":"18","key":"10.1016\/j.semradonc.2024.02.001_bib0073","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1158\/0008-5472.CAN-21-1500","article-title":"FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response","volume":"81","author":"Velalopoulou","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0074","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2022.05.014","article-title":"Pencil beam scanning proton FLASH maintains tumor control while normal tissue damage is reduced in a mouse model","volume":"175","author":"Sorensen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2022.05.003","article-title":"FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model","volume":"175","author":"Tinganelli","year":"2022","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0076","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1667\/RADE-19-00015.1","article-title":"Ultra-high dose-rate, pulsed (FLASH) radiotherapy with carbon ions: Generation of early, transient, highly oxygenated conditions in the tumor environment","volume":"194","author":"Zakaria","year":"2020","journal-title":"Radiat Res"},{"issue":"5","key":"10.1016\/j.semradonc.2024.02.001_bib0077","doi-asserted-by":"crossref","first-page":"055010","DOI":"10.1088\/1361-6560\/acb888","article-title":"Proton FLASH effects on mouse skin at different oxygen tensions","volume":"68","author":"Zhang","year":"2023","journal-title":"Phys Med Biol"},{"issue":"17","key":"10.1016\/j.semradonc.2024.02.001_bib0078","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-22-0262","article-title":"Dose- and volume-limiting late toxicity of FLASH radiotherapy in cats with squamous cell carcinoma of the nasal planum and in mini pigs","volume":"28","author":"Rohrer Bley","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0079","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1667\/RADE-20-00090","article-title":"FLASH irradiation results in reduced severe skin toxicity compared to conventional-dose-rate irradiation","volume":"194","author":"Soto","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2021.12.022","article-title":"In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH","volume":"167","author":"Singers Sorensen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0081","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1256760","article-title":"Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients","volume":"13","author":"Borresen","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0082","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.995612","article-title":"Mechanisms of FLASH effect","volume":"12","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.semradonc.2024.02.001_bib0083","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/biom12101376","article-title":"Radiobiological aspects of FLASH radiotherapy","volume":"12","author":"Hageman","year":"2022","journal-title":"Biomolecules"},{"issue":"20","key":"10.1016\/j.semradonc.2024.02.001_bib0084","doi-asserted-by":"crossref","first-page":"12109","DOI":"10.3390\/ijms232012109","article-title":"Potential molecular mechanisms behind the ultra-high dose rate \"FLASH\" effect","volume":"23","author":"Bogaerts","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.semradonc.2024.02.001_bib0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1667\/RADE-21-00232.1","article-title":"Oxygen monitoring in model solutions and in vivo in mice during proton irradiation at conventional and FLASH dose rates","volume":"198","author":"Van Slyke","year":"2022","journal-title":"Radiat Res"},{"issue":"1","key":"10.1016\/j.semradonc.2024.02.001_bib0086","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijrobp.2021.03.056","article-title":"Quantification of oxygen depletion during FLASH irradiation in vitro and in vivo","volume":"111","author":"Cao","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0087","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2022.03.016","article-title":"ultrafast tracking of oxygen dynamics during proton FLASH","volume":"113","author":"El Khatib","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"10.1016\/j.semradonc.2024.02.001_bib0088","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1073\/pnas.1901777116","article-title":"Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species","volume":"116","author":"Montay-Gruel","year":"2019","journal-title":"Proc Natl Acad Sci U S A,"},{"issue":"3","key":"10.1016\/j.semradonc.2024.02.001_bib0089","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/mp.15129","article-title":"Model studies of the role of oxygen in the FLASH effect","volume":"49","author":"Favaudon","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0090","first-page":"138","article-title":"Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies","volume":"38","author":"Zhu","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0091","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/bs.ircmb.2022.11.005","article-title":"Radiation-induced immune response in novel radiotherapy approaches FLASH and spatially fractionated radiotherapies","volume":"376","author":"Bertho","year":"2023","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0092","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3389\/fonc.2019.01291","article-title":"Emerging translational opportunities in comparative oncology with companion canine cancers: Radiation oncology","volume":"9","author":"Nolan","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0093","doi-asserted-by":"crossref","first-page":"658004","DOI":"10.3389\/fonc.2021.658004","article-title":"Establishment and initial experience of clinical FLASH radiotherapy in canine cancer patients","volume":"11","author":"Konradsson","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.semradonc.2024.02.001_bib0094","article-title":"Anesthetic oxygen use and sex are critical factors in the FLASH sparing effect","author":"Tavakkoli","year":"2023","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.semradonc.2024.02.001_bib0095","doi-asserted-by":"crossref","first-page":"101011","DOI":"10.1016\/j.adro.2022.101011","article-title":"Comparable long-term tumor control for hypofractionated FLASH versus conventional radiation therapy in an immunocompetent rat glioma model","volume":"7","author":"Konradsson","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"12","key":"10.1016\/j.semradonc.2024.02.001_bib0096","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","article-title":"Towards clinical translation of FLASH radiotherapy","volume":"19","author":"Vozenin","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"17","key":"10.1016\/j.semradonc.2024.02.001_bib0097","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1158\/1078-0432.CCR-22-1255","article-title":"Shining a FLASHlight on ultrahigh dose-rate radiation and possible late toxicity","volume":"28","author":"Maity","year":"2022","journal-title":"Clin Cancer Res"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962400002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105342962400002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T15:05:49Z","timestamp":1731596749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105342962400002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S105342962400002X"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2024.02.001","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}